Wakefit Innovations Ltd Q1 FY27 Earnings Analysis

- Wakefit aspires to grow at least about 20% at a company level considering multi-channel and multi-category variables (Page 18). - Volume growth is not a key performance indicator; focus is on ASP increase, product mix, cross-category sales, and repeat customer rates (Page 16). - Competitive intensity noted, but Wakefit prioritizes protecting and growing market share prudently (Page 18). - Larger organized players like Wakefit benefit from supply chain strength, potentially leading to accelerated volume growth despite price hikes, with higher growth rates seen in April compared to Q4 (Page 11). - For FY '27, positive volume growth is seen due to supply advantages, although exact volume CAGR is not disclosed (Page 11, 16). - With store expansion, including 80 planned new stores and 2 jumbo stores by FY '28, retail presence and revenue channels will grow (Page 15, 19). - Jumbo stores expected to break even in approximately 18 months, supporting future revenue growth (Page 19).

- Wakefit aspires to achieve at least 20% company-level growth despite inflationary and macroeconomic challenges. - Jumbo stores are expected to break even in about 18 to 24 months due to frugal, low-cost setups. - Focus remains on market share growth over margin expansion, though product and channel mix will be managed prudently to protect margins. - Advertising and marketing spends are anticipated to ramp up to around 7-8% of sales to support brand building. - EBITDA margins might face a minor contraction (1-2 percentage points) due to cost pressures but are expected to be maintained prudently over the full year. - The company is expanding product categories to improve repeat and cross-category sales, supporting sustained profitability. - Capex for FY27 expected between INR120-140 crores, largely for retail expansion including Jumbo stores, indicating investment in growth. - Operating EBITDA margin in Q4 FY26 stood at 6.3%, reported EBITDA margin at 12.2% for FY26, showing profitability trajectory.

- Wakefit plans significant capex for FY '27, estimated between INR120 crores to INR140 crores. - Approximately 60%-70% of this capex will be for the initial setup of Jumbo stores. - Jumbo stores are large format stores (100,000+ sq. ft.) aimed at completing the product portfolio and offering an aspirational experience. - Around 80 new stores are targeted to open in FY '27, including both regular and Jumbo stores. - Most capex will be retail-focused, not for manufacturing capacity expansion. - Strategic investment includes sourcing white-label products for adjacent categories like live plants and decor to complement core furniture and mattress lines, mainly stocked in Jumbo and select large flagship stores. - These new categories and store formats aim to enhance market presence cost-efficiently without heavy R&D or factory setup.

- No explicit mention of any current or planned future fundraising through debt or equity in the provided transcript. - The company has investable cash of around INR958 crores as of March 31, 2026. - Only INR4.5 crores out of the IPO proceeds (INR377 crores net of expenses) raised in December have been utilized so far. - The company emphasizes internal accruals and cash on hand rather than raising additional funds. - Capex for FY '27 is expected around INR120–140 crores, primarily funded through existing resources. - No indications of imminent debt or equity issuance; focus remains on prudent cost management and organic growth.

The provided pages from the Wakefit Innovations Limited document do not contain explicit information regarding the current or expected orderbook or pending orders. The discussion primarily focuses on: - Store expansion plans, including opening 80 regular stores in FY '27 and two jumbo stores planned for FY '28. - New product categories being added, such as live plants and decor items, primarily for jumbo stores. - Business strategy including supply chain, return policy, revenue growth, and market share protection. - Financial position including cash and IPO proceeds usage. No specific data on orderbook or pending orders is mentioned in these excerpts.